Stock-based Compensation

9 Months Ended

Nov. 30, 2013

Share-based Compensation [Abstract]

Stock-based Compensation

Stock-based Compensation.

The Company has one share-based compensation plan (the “Plan”). The purpose of the Plan is to promote the growth and prosperity of the Company by permitting the Company to grant to its employees, directors and advisors various types of restricted stock unit awards, stock appreciation rights and options to purchase common stock of the Company. The maximum number of shares that may be issued under the Plan is 5,000,000 shares. As of November 30, 2013 the Company has approximately 742,274 shares available for future issuance under the Plan.

Restricted Stock Unit Awards

Restricted stock unit awards are valued at the market price of our common stock on the grant date. These awards generally have a three year cliff vesting schedule but may vest early in accordance with the Plan’s accelerated vesting provisions.

The activity of our non-vested restricted stock unit awards for the nine month period endedNovember 30, 2013 is as follows:

	Restricted Stock  Units		Weighted Average  Grant Date Fair Value
Non-Vested Balance as of February 28, 2013	106,182		$	20.92
Granted	46,793		45.34
Vested	(81,283	)	22.77
Forfeited	—		—
Non-Vested Balance as of November 30, 2013	71,692		$	32.52

Stock Appreciation Rights and Option Awards

Stock appreciation rights and option awards are granted with an exercise price equal to the market value of our common stock on the date of grant. These awards generally have a contractual term of 7 years and vest ratably over a period of three years although some may vest immediately on issuance. These awards are valued using the Black-Scholes option pricing model.

A summary of the Company’s stock appreciation rights and option awards activity for the nine month period endedNovember 30, 2013 is as follows:

	Options/SAR’s		Weighted Average Exercise  Price
Outstanding as of February 28, 2013	439,863		$	19.12
Granted	112,381		45.33
Exercised	(135,380	)	19.08
Forfeited	—		—
Outstanding as of November 30, 2013	416,864		$	26.23
Exercisable as of November 30, 2013	240,076		$	19.85
Weighted average fair value of options and SARs granted during the period ended November 30, 2013			$	13.72

The average remaining contractual term for those options and stock appreciation rights outstanding at November 30, 2013 is 4.50 years, with an aggregate intrinsic value of $9.4 million. The average remaining contractual terms for those options and stock appreciation rights that are exercisable as of November 30, 2013 is 3.79 years, with an aggregate intrinsic value of $7.0 million.

Employee Stock Purchase Plan

The Company also has an employee stock purchase plan, which allows employees of the Company to purchase common stock of the Company through accumulated payroll deductions. Offerings under this plan have a duration of 24 months. On the first day of an offering period (the "enrollment date") the participant is granted the option to purchase shares on each exercise date at the lower of 85% of the market value of a share of our common stock on the enrollment date or the exercise date. The participant’s right to purchase common stock under the plan is restricted to no more than $25,000 per calendar year and the participant may not purchase more than 5,000 shares during any offering period. Participants may terminate their interest in a given offering or a given exercise period by withdrawing all of their accumulated payroll deductions at any time prior to the end of the offering period. The fair value of the estimated number of shares to be issued under each offering is determined using the Black-Scholes option pricing model. For the nine month period ended November 30, 2013, the Company issued 62,949 shares under the Employee Stock Purchase Plan.

Directors Grants

During the second quarter of fiscal 2014, the Company granted each of its seven independent directors 2,000 shares of the Company's common stock. These common stock grants were valued at $36.70 per share. As previously stated all per share data has been adjusted to reflect the two for one stock split undertaken in fiscal 2013.

Share-based compensation expense and related income tax benefits related to all the plans listed above were as follows:

Period ended November 30,	2013		2012
Compensation Expense	$	2,988,596	$	2,816,827
Income tax benefits	$	1,046,009	$	985,889

Unrecognized compensation cost related to stock appreciation rights, restricted stock units and the employee stock purchase plan at November 30, 2013 totals $3,449,797.

The Company’s policy is to issue shares required under these plans from the Company’s authorized but unissued shares and treasury.